Digital healthcare company BrainCheck has announced an additional $13 million in Series A financing to strengthen its AI in healthcare strategy and expand its enterprise cognitive care infrastructure. The funding round was led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises, signaling strong investor confidence in scalable, technology-enabled cognitive care models.
The new capital will accelerate expansion of BrainCheck’s digital medical platform, focusing on deeper workflow integration, longitudinal patient monitoring, and population-scale deployment across primary care and specialty settings. As healthcare systems increasingly transition toward value-based and risk-bearing environments, AI-assisted clinical infrastructure is becoming essential for managing cognitive health at scale.
Health Technology Insights: https://healthtechnologyinsights.com/how-health-technology-is-strengthening-global-healthcare-access/
BrainCheck is also partnering with collaborative care organizations to operationalize cognitive care delivery within practices that lack dedicated staffing or infrastructure. By extending beyond digital assessment into structured cognitive care pathways, the company supports healthcare providers with both advanced technology and operational enablement models – helping patients receive earlier detection and coordinated follow-up care.
As populations age and demand for dementia and Alzheimer’s disease screening grows, standardized digital cognitive assessment is becoming the entry point for modern medical care pathways. BrainCheck’s platform enables providers to identify cognitive impairment earlier and activate repeatable, evidence-based monitoring over time.
BrainCheck is currently used by more than 500 healthcare organizations nationwide, with over 640,000 cognitive assessments completed using BrainCheck Assess™, its FDA Class II digital cognitive assessment solution. The platform includes 29 validated cognitive screeners and care planning tools, integrated directly into electronic health record workflows. Testing protocols are customizable and available in English and Spanish, supporting clinicians across primary care, neurology, and psychiatry.
The company’s strategic focus centers on five pillars: earlier identification of cognitive risk, objective and repeatable assessment over time, AI-assisted population health analytics, seamless EHR integration, and coordinated care across clinical teams. Importantly, the platform is designed to reduce operational burden while ensuring that all interpretation and medical decision-making remain clinician-directed.
Leadership emphasized that the funding will help reduce friction in time-constrained clinical environments while responsibly using AI in healthcare to support – not replace – physician expertise. With blood-based biomarkers and emerging therapies reshaping cognitive care pathways, digital cognitive assessment is increasingly guiding risk stratification and specialty referrals.
As healthcare organizations and accountable care models take greater responsibility for patient outcomes, BrainCheck’s standardized digital infrastructure positions it as a key enabler of scalable, AI-powered cognitive healthcare delivery nationwide.
Health Technology Insights: https://healthtechnologyinsights.com/the-patient-journey-problem-that-healthcare-technology-must-solve/
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
